Yano Y, Kambayashi J, Shiba E, Sakon M, Oiki E, Fukuda K, Kawasaki T, Mori T
Department of Surgery II, Osaka University Medical School, Japan.
Biochem J. 1994 Apr 1;299 ( Pt 1)(Pt 1):303-8. doi: 10.1042/bj2990303.
Platelets activated by various agonists produce vesicles (microparticles; MPs) from the plasma membrane. However, the mechanism of this MP formation remains to be elucidated. To investigate the possible involvement of protein phosphorylation and cytoskeletal reorganization in MP formation, the effects of various inhibitors on MP formation were investigated. Flow cytometry was employed to detect the amount of MP formation by using monoclonal antibodies against glycoprotein (GP) IIb-IIIa (NNKY 1-32) or GPIIb (Tab). The relationship between changes in cytoskeletal architecture and MP formation in the platelets activated by thrombin plus collagen was observed by scanning electron microscopy (SEM). MPs were observed in the vicinity of the terminals of pseudopods, suggesting that MPs may be related by budding of the pseudopods. Cytochalasin D (10 microM) inhibited MP formation from the activated platelets almost completely. Moreover, SEM of the cytochalasin D-treated platelets revealed the absence of shape change, pseudopod formation and MPs. These findings suggest that cytoskeletal reorganization is necessary for MP formation. Since cytoskeletal reorganization is considered to be regulated by a dynamic phosphorylation-dephosphorylation process, we investigated the effects of the protein phosphatase inhibitors, calyculin A (CLA) and okadaic acid (OA), on MP formation. Flow cytometry showed that these two inhibitors doubled MP formation in activated platelets. SEM of the platelets treated with CLA or OA demonstrated more prominent shape change and pseudopod formation in these platelets than in those without inhibitor. From these results, we conclude that cytoskeletal reorganization, which is controlled by phosphorylation, is involved in MP formation.
由各种激动剂激活的血小板会从质膜产生囊泡(微粒;MPs)。然而,这种MP形成的机制仍有待阐明。为了研究蛋白质磷酸化和细胞骨架重组在MP形成中可能的作用,研究了各种抑制剂对MP形成的影响。采用流式细胞术,使用抗糖蛋白(GP)IIb-IIIa(NNKY 1-32)或GPIIb(Tab)的单克隆抗体来检测MP形成的量。通过扫描电子显微镜(SEM)观察凝血酶加胶原蛋白激活的血小板中细胞骨架结构变化与MP形成之间的关系。在伪足末端附近观察到MPs,这表明MPs可能与伪足的出芽有关。细胞松弛素D(10 microM)几乎完全抑制了活化血小板中MP的形成。此外,经细胞松弛素D处理的血小板的SEM显示没有形状变化、伪足形成和MPs。这些发现表明细胞骨架重组是MP形成所必需的。由于细胞骨架重组被认为受动态磷酸化-去磷酸化过程调控,我们研究了蛋白磷酸酶抑制剂花萼海绵诱癌素A(CLA)和冈田酸(OA)对MP形成的影响。流式细胞术显示这两种抑制剂使活化血小板中的MP形成增加了一倍。用CLA或OA处理的血小板的SEM显示,与未用抑制剂处理的血小板相比,这些血小板的形状变化和伪足形成更明显。从这些结果中,我们得出结论,由磷酸化控制的细胞骨架重组参与了MP的形成。